본문 바로가기
KERD
논문KCI 등재

Introduction to cerebral cavernous malformation: a brief review

김재홍
생화학분자생물학회 (Korean Society Of Biochemistry And Molecular Biology)|2016.05|BMB Reports|제49권 제5호|pp. 255-262

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

SignalingCentral nervous systemAngiogenesisCerebral cavernous malformationVascular permeability
주제분류화학

초록

The disease known as cerebral cavernous malformations mostly occurs in the central nervous system, and their typical histological presentations are multiple lumen formation and vascular leakage at the brain capillary level, resulting in disruption of the blood-brain barrier. These abnormalities result in severe neurological symptoms such as seizures, focal neurological deficits and hemorrhagic strokes. CCM research has identified ‘loss of function’ mutations of three ccm genes responsible for the disease and also complex regulation of multiple signaling pathways including the WNT/-catenin pathway, TGF- and Notch signaling by the ccm genes. Although CCM research is a relatively new and small scientific field, as CCM research has the potential to regulate systemic blood vessel permeability and angiogenesis including that of the blood-brain barrier, this field is growing rapidly. In this review, I will provide a brief overview of CCM pathogenesis and function of ccm genes based on recent progress in CCM research.

Abstract

The disease known as cerebral cavernous malformations mostly occurs in the central nervous system, and their typical histological presentations are multiple lumen formation and vascular leakage at the brain capillary level, resulting in disruption of the blood-brain barrier. These abnormalities result in severe neurological symptoms such as seizures, focal neurological deficits and hemorrhagic strokes. CCM research has identified ‘loss of function’ mutations of three ccm genes responsible for the disease and also complex regulation of multiple signaling pathways including the WNT/-catenin pathway, TGF- and Notch signaling by the ccm genes. Although CCM research is a relatively new and small scientific field, as CCM research has the potential to regulate systemic blood vessel permeability and angiogenesis including that of the blood-brain barrier, this field is growing rapidly. In this review, I will provide a brief overview of CCM pathogenesis and function of ccm genes based on recent progress in CCM research.

참고문헌 (96)

  1. Cavalcanti DD, "Cerebral cavernous malformations:from genes to proteins to disease", J Neurosurg, 116, pp.122~132 (2012)
  2. Kumar A, "Surveying genetic variants, molecular phylogeny of cerebral cavernous malformation gene, CCM3", PDCD10, 2014, pp.455, 98~106
  3. Choquet H, "Genetics of cerebral cavernous malformations: current status, future prospects", J Neurosurg Sci, 59, pp.211~220 (2015)
  4. Labauge P, "Genetics of cavernous angiomas", Lancet Neurol, 6, pp.237~244 (2007)
  5. Rigamonti D, "Cerebral cavernous malformations. Incidence, familial occurrence", N Engl J Med, 319, pp.343~347 (1988)
  6. Pozzati E, "Growth, subsequent bleeding, and de novo appearance of cerebral cavernous angiomas", Neurosurgery, 38, pp.662~670 (1996)
  7. Meliton A, "Role of Krev Interaction Trapped-1 in Prostacyclin-Induced Protection against Lung Vascular Permeability Induced by Excessive Mechanical Forces, Thrombin Receptor Activating Peptide 6", Am J Respir Cell Mol Biol, 53, pp.834~843 (2015)
  8. Stockton RA, "Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity", J Exp Med, 207, pp.881~896 (2010)
  9. Stamatovic SM, "PDCD10 (CCM3) regulates brain endothelial barrier integrity in cerebral cavernous malformation type 3: role of CCM3-ERK1", 2-cortactin cross-talk, 2015, pp.130, 731~750
  10. Bravi L, "Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice", Proc Natl Acad Sci U S A, 112, pp.8421~8426 (2015)
  11. Glading AJ, "Rap1, its effector KRIT1", CCM1 regulate beta-catenin signaling, 2010, pp.3, 73~83
  12. Maddaluno L, "EndMT contributes to the onset, progression of cerebral cavernous malformations", Nature, 498, pp.492~496 (2013)
  13. Cuttano R, "KLF4 is a key determinant in the development, progression of cerebral cavernous malformations", EMBO Mol Med, 8, pp.6~24 (2015)
  14. Schulz GB, "Cerebral Cavernous Malformation-1 Protein Controls DLL4-Notch3 Signaling Between the Endothelium, Pericytes", Stroke, 46, pp.1337~1343 (2015)
  15. Glading A, "KRIT-1", CCM1 is a Rap1 effector that regulates endothelial cell cell junctions, 2007, pp.179, 247~254
  16. Moglia A, "Evaluation of the bioactive properties of avenanthramide analogs produced in recombinant yeast", Biofactors, 41, pp.15~27 (2015)
  17. Goitre L, "KRIT1 loss of function causes a ROS-dependent upregulation of c-Jun", Free Radic Biol Med, 68, pp.134~147 (2014)
  18. Goitre L, "KRIT1 regulates the homeostasis of intracellular reactive oxygen species", PLoS One, 5, pp.e11786~ (2010)
  19. Baxter SS, "Role of cytoskeletal proteins in cerebral cavernous malformation signaling pathways: a proteomic analysis", Mol Biosyst, 10, pp.1881~1889 (2014)
  20. Jung KH, "Proteomic analysis reveals KRIT1 as a modulator for the antioxidant effects of valproic acid in human bone-marrow mesenchymal stromal cells", Drug Chem Toxicol, 38, pp.286~292 (2015)
  21. Kim J, "Phosphorylation sites in the cerebral cavernous malformations complex", J Cell Sci, 124, pp.3929~3932 (2011)
  22. Sahoo T, "Mutations in the gene encoding KRIT1, a Krev-1", rap1a binding protein, cause cerebral cavernous malformations(CCM1), 1999, pp.8, 2325~2333
  23. Liquori CL, "Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations", Am J Hum Genet, 73, pp.1459~1464 (2003)
  24. Bergametti F, "Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations", Am J Hum Genet, 76, pp.42~51 (2005)
  25. Craig HD, "Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13, 3q25. 2-27", Hum Mol Genet, 7, pp.1851~1858 (1998)
  26. Dubovsky J, "A gene responsible for cavernous malformations of the brain maps to chromosome 7q", Hum Mol Genet, 4, pp.453~458 (1995)
  27. Riant F, "Recent insights into cerebral cavernous malformations: the molecular genetics of CCM", FEBS J, 277, pp.1070~1075 (2010)
  28. Draheim KM, "Cerebral cavernous malformation proteins at a glance", J Cell Sci, 127, pp.701~707 (2014)
  29. Spiegler S, "High mutation detection rates in cerebral cavernous malformation upon stringent inclusion criteria: one-third of probands are minors", Mol Genet Genomic Med, 2, pp.176~185 (2014)
  30. Denier C, "Genotypephenotype correlations in cerebral cavernous malformations patients", Ann Neurol, 60, pp.550~556 (2006)
  31. Riant F, "CCM molecular screening in a diagnosis context: novel unclassified variants leading to abnormal splicing, importance of large deletions", Neurogenetics, 14, pp.133~141 (2013)
  32. Mondejar R, "Molecular diagnosis in cerebral cavernous malformations", Neurologia (2015)
  33. D'Angelo R, "Mutation analysis of CCM1, CCM2, CCM3 genes in a cohort of Italian patients with cerebral cavernous malformation", Brain Pathol, 21, pp.215~224 (2011)
  34. D'Angelo R, "Sporadic cerebral cavernous malformations: report of further mutations of CCM genes in 40 Italian patients", Biomed Res Int, 2013, pp.459253~ (2013)
  35. Tsutsumi S, "Genomic causes of multiple cerebral cavernous malformations in a Japanese population", J Clin Neurosci, 20, pp.667~669 (2013)
  36. Verlaan DJ, "CCM1 mutation screen of sporadic cases with cerebral cavernous malformations", Neurology, 62, pp.1213~1215 (2004)
  37. Chan AC, "Mutations in 2distinct genetic pathways result in cerebral cavernous malformations in mice", J Clin Invest, 121, pp.1871~1881 (2011)
  38. Yoruk B, "Ccm3functions in a manner distinct from Ccm1, Ccm2 in a zebrafish model of CCM vascular disease", Dev Biol, 362, pp.121~131 (2012)
  39. Song Y, "Focal defects in single-celled tubes mutant for Cerebral cavernous malformation 3, GCKIII, or NSF2", Dev Cell, 25, pp.507~519 (2013)
  40. Zawistowski JS, "CCM1and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis", Hum Mol Genet, 14, pp.2521~2531 (2005)
  41. Fisher OS, "Structural basis for the disruption of the cerebral cavernous malformations 2(CCM2)interaction with Krev interaction trapped 1(KRIT1)by disease-associated mutations", J Biol Chem, 290, pp.2842~2853 (2015)
  42. Zhu Y, "Differential angiogenesis function of CCM2, CCM3 in cerebral cavernous malformations", Neurosurg Focus, 29, pp.E1~ (2010)
  43. McDonald DA, "Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis", Hum Mol Genet, 23, pp.4357~4370 (2014)
  44. Gault J, "Biallelic somatic, germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion", Stroke, 36, pp.872~874 (2005)
  45. Kehrer-Sawatzki H, "Mutation, expression analysis of the KRIT1 gene associated with cerebral cavernous malformations(CCM1)", Acta Neuropathol, 104, pp.231~240 (2002)
  46. Pagenstecher A, "A two-hit mechanism causes cerebral cavernous malformations:complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells", Hum Mol Genet, 18, pp.911~918 (2009)
  47. Jaffe AB, "Rho GTPases: biochemistry, biology", Annu Rev Cell Dev Biol, 21, pp.247~269 (2005)
  48. Borikova AL, "Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype", J Biol Chem, 285, pp.11760~11764 (2010)
  49. Faurobert E, "CCM1-ICAP-1 complex controls beta1 integrin-dependent endothelial contractility, fibronectin remodeling", J Cell Biol, 202, pp.545~561 (2013)
  50. Whitehead KJ, "The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases", Nat Med, 15, pp.177~184 (2009)
  51. Wustehube J, "Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling", Proc Natl Acad Sci U S A, 107, pp.12640~12645 (2010)
  52. Brutsch R, "Integrin cytoplasmic domain-associated protein-1 attenuates sprouting angiogenesis", Circ Res, 107, pp.592~601 (2010)
  53. You C, "Loss of CCM3 impairs DLL4-Notch signalling:implication in endothelial angiogenesis, in inherited cerebral cavernous malformations", J Cell Mol Med, 17, pp.407~418 (2013)
  54. Marchi S, "Defective autophagy is a key feature of cerebral cavernous malformations", EMBO Mol Med, 7, pp.1403~1417 (2015)
  55. DiStefano PV, "KRIT1 protein depletion modifies endothelial cell behavior via increased vascular endothelial growth factor(VEGF)signaling", J Biol Chem, 289, pp.33054~33065 (2014)
  56. Zhu Y, "Loss of endothelial programmed cell death 10 activates glioblastoma cells, promotes tumor growth", Neuro Oncol, 18, pp.538~548 (2015)
  57. Gore AV, "Combinatorial interaction between CCM pathway genes precipitates hemorrhagic stroke", Dis Model Mech, 1, pp.275~281 (2008)
  58. Rinaldi C, "Glyoxalase I A111e, Paraoxonase 1 Q192r, L55m Polymorphisms in Italian Patients with Sporadic Cerebral Cavernous Malformations: A Pilot Study", J Biol Regul Homeost Agents, 29, pp.493~500 (2015)
  59. Guazzi P, "Identification of the Kelch Family Protein Nd1-L as a Novel Molecular Interactor of KRIT1", PLoS One, 7, pp.e44705~ (2012)
  60. Boulday G, "Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice", J Exp Med, 208, pp.1835~1847 (2011)
  61. McDonald DA, "A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease", Hum Mol Genet, 20, pp.211~222 (2011)
  62. Rosen JN, "ccm2-like is required for cardiovascular development as a novel component of the Heg-CCM pathway", Dev Biol, 376, pp.74~85 (2013)
  63. Zhou Z, "The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling, KLF expression", Dev Cell, 32, pp.168~180 (2015)
  64. Cullere X, "The cerebral cavernous malformation proteins CCM2L, CCM2 prevent the activation of the MAP kinase MEKK3", Proc Natl Acad Sci U S A, 112, pp.14284~14289 (2015)
  65. Zheng X, "Cerebral cavernous malformations arise independent of the heart of glass receptor", Stroke, 45, pp.1505~1509 (2014)
  66. Plummer NW, "Loss of p53 sensitizes mice with a mutation in Ccm1(KRIT1)to development of cerebral vascular malformations", Am J Pathol, 165, pp.1509~1518 (2004)
  67. Shenkar R, "Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations", Genet Med, 17, pp.188~196 (2015)
  68. Stahl S, "Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1", CCM2, Hum Mutat, pp.2008, 29[DOI]
  69. Voss K, "CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations", Neurogenetics, 8, pp.249~256 (2007)
  70. Goudreault M, "A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase, kinase complex linked to the cerebral cavernous malformation 3(CCM3)protein", Mol Cell Proteomics, 8, pp.157~171 (2009)
  71. Edelmann AR, "Systems biology, proteomic analysis of cerebral cavernous malformation", Expert Rev Proteomics, 11, pp.395~404 (2014)
  72. Hilder TL, "Proteomic identification of the cerebral cavernous malformation signaling complex", J Proteome Res, 6, pp.4343~4355 (2007)
  73. Draheim KM, "CCM2-CCM3 interaction stabilizes their protein expression, permits endothelial network formation", J Cell Biol, 208, pp.987~1001 (2015)
  74. Li X, "Crystal structure of CCM3, a cerebral cavernous malformation protein critical for vascular integrity", J Biol Chem, 285, pp.24099~24107 (2010)
  75. Fisher OS, "Signaling pathways, the cerebral cavernous malformations proteins: lessons from structural biology", Cell Mol Life Sci, 71, pp.1881~1892 (2014)
  76. Liu W, "Mechanism for KRIT1 release of ICAP1-mediated suppression of integrin activation", Mol Cell, 49, pp.719~729 (2013)
  77. Gunel M, "KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein", Proc Natl Acad Sci U S A, 99, pp.10677~10682 (2002)
  78. Beraud-Dufour S, "Krit 1 interactions with microtubules, membranes are regulated by Rap1, integrin cytoplasmic domain associated protein-1", FEBS J, 274, pp.5518~5532 (2007)
  79. Liu JJ, "A mechanism of Rap1-induced stabilization of endothelial cell--cell junctions", Mol Biol Cell, 22, pp.2509~2519 (2011)
  80. Li X, "Structural basis for small G protein effector interaction of Ras-related protein 1(Rap1), adaptor protein Krev interaction trapped 1(KRIT1)", J Biol Chem, 287, pp.22317~22327 (2012)
  81. Gingras AR, "The structure of the ternary complex of Krev interaction trapped 1(KRIT1)bound to both the Rap1 GTPase, the heart of glass(HEG1)cytoplasmic tail", J Biol Chem, 288, pp.23639~23649 (2013)
  82. Stiegler AL, "Structural determinants for binding of sorting nexin 17(SNX17)to the cytoplasmic adaptor protein Krev interaction trapped 1(KRIT1)", J Biol Chem, 289, pp.25362~25373 (2014)
  83. Fisher OS, "Structure, vascular function of MEKK3-cerebral cavernous malformations 2 complex", Nat Commun, 6, pp.7937~ (2015)
  84. Crose LE, "Cerebral cavernous malformation 2 protein promotes smad ubiquitin regulatory factor 1-mediated RhoA degradation in endothelial cells", J Biol Chem, 284, pp.13301~13305 (2009)
  85. Li X, "Molecular recognition of leucine-aspartate repeat(LD)motifs by the focal adhesion targeting homology domain of cerebral cavernous malformation 3(CCM3)", J Biol Chem, 286, pp.26138~26147 (2011)
  86. Zhang M, "Structural mechanism of CCM3 heterodimerization with GCKIII kinases", Structure, 21, pp.680~688 (2013)
  87. Voss K, "Functional analyses of human, zebrafish 18-amino acid in-frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 protein", Hum Mutat, 30, pp.1003~1011 (2009)
  88. Ceccarelli DF, "CCM3", PDCD10 heterodimerizes with germinal center kinase III(GCKIII)proteins using a mechanism analogous to CCM3 homodimerization, 2011, pp.286, 25056~25064
  89. Fidalgo M, "CCM3", PDCD10 stabilizes GCKIII proteins to promote Golgi assembly, cell orientation, 2010, pp.123, 1274~1284
  90. Kean MJ, "Structure-function analysis of core STRIPAK Proteins: a signaling complex implicated in Golgi polarization", J Biol Chem, 286, pp.25065~25075 (2011)
  91. He Y, "Stabilization of VEGFR2signaling by cerebral cavernous malformation 3 is critical for vascular development", Sci Signal, 3, pp.ra26~ (2010)
  92. Dibble CF, "Defining the functional domain of programmed cell death 10 through its interactions with phosphatidylinositol-3, 4, 5-trisphosphate", PLoS One, 5, pp.e11740~ (2010)
  93. Mouchtouris N, "Management of cerebral cavernous malformations: from diagnosis to treatment", ScientificWorldJournal, 2015, pp.808314~ (2015)
  94. McDonald DA, "Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease", Stroke, 43, pp.571~574 (2012)
  95. Westover MB, "Statin use following intracerebral hemorrhage:a decision analysis", Arch Neurol, 68, pp.573~579 (2011)
  96. Mikati AG, "Vascular permeability in cerebral cavernous malformations", J Cereb Blood Flow Metab, 35, pp.1632~1639 (2015)

관련 논문AI추천

Single-cell sequencing reveals that endothelial cells, EndMT cells and mural cells contribute to the pathogenesis of cavernous malformationsHongqi Zhang, Jian Ren, Leiming Wang, Li Ruofei, Lv Cheng, Tao Hong, Wang Yibo, Xiao Xiao, Zhang Yu생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권 The Pathophysiology of Moyamoya Disease: An Update김승기, 방오영, Miki Fujimura대한뇌졸중학회 · 대한뇌졸중영문학회지2016 · 제18권 제1호A Sudden Unexpected Death in an Epileptic with Cerebral Cavernous Angioma권태정, 김유훈, 김형중, 박종필대한법의학회 · 대한법의학회지2010 · 제34권 제1호Neuropathologic features of central nervous system hemangioblastomaPatrick J. Cimino, Rebecca A. Yoda대한병리학회 · Journal of Pathology and Translational Medicine2022 · 제56권 제3호A Case of Widespread Cavernous Malformations of the Central Nervous System Associated with Acute Neurologic Deficit노경철, 이도경, 정성은대한자기공명의과학회 · Investigative Magnetic Resonance Imaging2017 · 제21권 제1호Cerebral Amyloid Angiopathy: A Systematic ReviewAlessandro Biffi, Steven M. Greenberg대한신경과학회 · Journal of Clinical Neurology2011 · 제7권 제1호

이 간행물의 다른 논문 (10건)

Regulation of HIF-1α stability by lysine methylation백성희, 김근일pp. 245-246New role of E3 ubiquitin ligase in the regulation of necroptosis이은우, 송재환, 서진호pp. 247-248Spot the difference: Solving the puzzle of hidden pictures in the lizard genome for identification of regeneration factors정진웅pp. 249-254MicroRNA-orchestrated pathophysiologic control in gut homeostasis and inflammation키요노히로시, Juneyoung Lee, Eun Jeong Parkpp. 263-269Proteasome inhibitors attenuated cholesterol-induced cardiac hypertrophy in H9c2 cells송은주, 박진영, 김은경, 유영숙, 이현정pp. 270-275
원문 보기